Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Specific gut microbiome signature predicts the early-stage lung cancer
Yajuan Zheng, Zhaoyuan Fang, Yun Xue, et al.
Gut Microbes (2020) Vol. 11, Iss. 4, pp. 1030-1042
Open Access | Times Cited: 203

Showing 1-25 of 203 citing articles:

Gut microbiome, big data and machine learning to promote precision medicine for cancer
Giovanni Cammarota, Gianluca Ianiro, Anna M. Ahern, et al.
Nature Reviews Gastroenterology & Hepatology (2020) Vol. 17, Iss. 10, pp. 635-648
Closed Access | Times Cited: 242
Role of lung and gut microbiota on lung cancer pathogenesis
Yue Zhao, Yuxia Liu, Shuang Li, et al.
Journal of Cancer Research and Clinical Oncology (2021) Vol. 147, Iss. 8, pp. 2177-2186
Open Access | Times Cited: 142
Gut microbiota: A new insight into lung diseases
Peijun Ma, Mengmeng Wang, Yun Wang
Biomedicine & Pharmacotherapy (2022) Vol. 155, pp. 113810-113810
Open Access | Times Cited: 84
Gut microbiota and risk of five common cancers: A univariable and multivariable Mendelian randomization study
Zixin Wei, Biying Yang, Tiantian Tang, et al.
Cancer Medicine (2023) Vol. 12, Iss. 9, pp. 10393-10405
Open Access | Times Cited: 57
Distribution and roles of Ligilactobacillus murinus in hosts
Zhou Chuandong, Jicong Hu, Jiawen Li, et al.
Microbiological Research (2024) Vol. 282, pp. 127648-127648
Closed Access | Times Cited: 18
Molecular crosstalk between polyphenols and gut microbiota in cancer prevention
Falak Zeb, Huma Naqeeb, Tareq M. Osaili, et al.
Nutrition Research (2024) Vol. 124, pp. 21-42
Closed Access | Times Cited: 17
Gut–X axis
Lin Xu, Yu Zhang, Xueyan Li, et al.
iMeta (2025) Vol. 4, Iss. 1
Open Access | Times Cited: 2
Microbiome dysbiosis in lung cancer: from composition to therapy
Ningning Liu, Qiang Ma, Yang Ge, et al.
npj Precision Oncology (2020) Vol. 4, Iss. 1
Open Access | Times Cited: 103
Gut microbiota regulate tumor metastasis via circRNA/miRNA networks
Zhuxian Zhu, Jianguo Huang, Li Xu, et al.
Gut Microbes (2020) Vol. 12, Iss. 1, pp. 1788891-1788891
Open Access | Times Cited: 90
Edible fungal polysaccharides, the gut microbiota, and host health
Jingjing Liang, Meina Zhang, Xingnan Wang, et al.
Carbohydrate Polymers (2021) Vol. 273, pp. 118558-118558
Closed Access | Times Cited: 84
The Role of Gut Microbiota in Lung Cancer: From Carcinogenesis to Immunotherapy
Xiangjun Liu, Ye Cheng, Dan Zang, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 79
Dysbiosis of gut microbiota in patients with esophageal cancer
Yali Deng, Derong Tang, Pan‐Fei Hou, et al.
Microbial Pathogenesis (2020) Vol. 150, pp. 104709-104709
Closed Access | Times Cited: 75
Specific Gut Microbiome and Serum Metabolome Changes in Lung Cancer Patients
Feng Zhao, Rui An, Liqian Wang, et al.
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 75
Dysbiosis of skin microbiome and gut microbiome in melanoma progression
Chahrazed Mekadim, Helena Kupcová Skalníková, Jana Čížková, et al.
BMC Microbiology (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 67
Unlocking the Potential of the Human Microbiome for Identifying Disease Diagnostic Biomarkers
Rima Hajjo, Dima A. Sabbah, Abdel Qader Al Bawab
Diagnostics (2022) Vol. 12, Iss. 7, pp. 1742-1742
Open Access | Times Cited: 51
The Intratumoral Bacterial Metataxonomic Signature of Hepatocellular Carcinoma
Jian-Hang Huang, Jie Wang, Xiaoqiang Chai, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 5
Open Access | Times Cited: 50
Microbiota and lung cancer
Taichiro Goto
Seminars in Cancer Biology (2022) Vol. 86, pp. 1-10
Open Access | Times Cited: 49
Gut microbiome alteration as a diagnostic tool and associated with inflammatory response marker in primary liver cancer
Tuo Deng, Jialiang Li, Bangjie He, et al.
Hepatology International (2022) Vol. 16, Iss. 1, pp. 99-111
Closed Access | Times Cited: 39
Presence of Akkermansiaceae in gut microbiome and immunotherapy effectiveness in patients with advanced non-small cell lung cancer
Anna Grenda, Ewelina Iwan, Izabela Chmielewska, et al.
AMB Express (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 38
The human microbiome and cancer: a diagnostic and therapeutic perspective
Shruthi Kandalai, Huapeng Li, Nan Zhang, et al.
Cancer Biology & Therapy (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 38
Statistical normalization methods in microbiome data with application to microbiome cancer research
Yinglin Xia
Gut Microbes (2023) Vol. 15, Iss. 2
Open Access | Times Cited: 29
EGCG alleviates obesity-exacerbated lung cancer progression by STAT1/SLC7A11 pathway and gut microbiota
Fan Li, Shengyu Hao, Jian Gao, et al.
The Journal of Nutritional Biochemistry (2023) Vol. 120, pp. 109416-109416
Closed Access | Times Cited: 28
Gut microbiota dysbiosis promotes the development of epithelial ovarian cancer via regulating Hedgehog signaling pathway
Xinyue Hu, Xuan Xu, Xiangdi Zeng, et al.
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 27
Immunomodulatory Properties of Probiotics and Their Derived Bioactive Compounds
Christina Thoda, Maria Touraki
Applied Sciences (2023) Vol. 13, Iss. 8, pp. 4726-4726
Open Access | Times Cited: 26
Combined analysis of gut microbiome and serum metabolomics reveals novel biomarkers in patients with early-stage non-small cell lung cancer
Boxiong Ni, Xianglong Kong, Yubo Yan, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 25
Page 1 - Next Page

Scroll to top